# Melatonin for Prevention of Kidney Injury

> **NCT05084196** · PHASE3 · RECRUITING · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 300 (estimated)

## Conditions studied

- Acute Kidney Injury
- Adverse Drug Event

## Interventions

- **DRUG:** Melatonin
- **OTHER:** Placebo Capsule

## Key facts

- **NCT ID:** NCT05084196
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-05
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05084196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05084196, "Melatonin for Prevention of Kidney Injury". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05084196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*